Literature DB >> 23861538

Intermittent drug techniques for schizophrenia.

Stephanie Sampson1, Kajal Joshi, Mouhamad Mansour, Clive E Adams.   

Abstract

Intermittent drug techniques refer to the "use of medication only during periods of incipient relapse or symptom exacerbation rather than continuously." The aim is to reduce the risk of adverse effects of antipsychotics by "reducing long-term medication exposure for patients who are receiving maintenance treatment while limiting risk of relapse," with a further goal of improving social functioning resulting from the reduction of antipsychotic-induced side effects. We reviewed the effects of different intermittent drug techniques compared with maintenance treatment in people with schizophrenia or related disorders. We searched The Cochrane Schizophrenia Group Trials Register (April 2012) and supplemented this by contacting relevant study authors and manually searching reference lists. All relevant randomized controlled trials (RCTs) were included.Of 241 records retrieved by the search, 17 trials were included. Homogenous data demonstrated that instances of relapse were significantly higher in people receiving any intermittent drug treatment in the long term (n=436, 7 RCTs, RR=2.46, 95% CI=1.70- to 3.54). Intermittent treatment was shown to be more effective than placebo, however, and demonstrated that significantly less people receiving intermittent antipsychotics experienced full relapse by medium term (n=290, 2 RCTs, RR=0.37, 95% CI=0.24-0.58). Intermittent antipsychotic treatment is not as effective as continuous, maintained antipsychotic therapy for preventing relapse in people with schizophrenia. It does seem, however, significantly better than no treatment.

Entities:  

Keywords:  intermittent; meta-analysis; schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 23861538      PMCID: PMC3756794          DOI: 10.1093/schbul/sbt096

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  1 in total

Review 1.  Intermittent drug techniques for schizophrenia.

Authors:  Stephanie Sampson; Mouhamad Mansour; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2013-07-20
  1 in total
  8 in total

1.  [Quantum of luck with a self-induced penetrating orbital injury].

Authors:  A Bajor; K Calvelli; E Janke; P Bialon; J Lang; E Bültmann; I Brunotte; C Framme
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

Review 2.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 3.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

4.  Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database.

Authors:  Kangyuan Guo; Zhanchun Feng; Shanquan Chen; Ziqi Yan; Zhiming Jiao; Da Feng
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 5.  Asenapine Transdermal Patch for the Management of Schizophrenia.

Authors:  Maxine Zhou; Sahar Derakhshanian; Alexander Rath; Sarah Bertrand; Caroline DeGraw; Rachel Barlow; Aja Menard; Adam M Kaye; Jamal Hasoon; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2020-09-14

Review 6.  A Review of Clinical and Economic Evaluations Applied to Psychotropic Therapies Used in the Treatment of Schizophrenia in Argentina.

Authors:  Gisela Paula González; Nebel Silvana Moscoso; Fernando Pablo Lago
Journal:  Pharmacoecon Open       Date:  2018-09

7.  Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  W Wolfgang Fleischhacker; Mary Hobart; John Ouyang; Andy Forbes; Stephanie Pfister; Robert D McQuade; William H Carson; Raymond Sanchez; Margareta Nyilas; Emmanuelle Weiller
Journal:  Int J Neuropsychopharmacol       Date:  2017-01-01       Impact factor: 5.176

8.  Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting.

Authors:  Rosaria Di Lorenzo; Paola Ferri; Michela Cameli; Sergio Rovesti; Chiara Piemonte
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-07       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.